American Bio Medica Corporation Announces Patent Award for Its Rapid TOX Cup® II and InCup® Product Lines

Published: Jun 26, 2012

KINDERHOOK, N.Y.--(BUSINESS WIRE)--American Bio Medica Corporation (ABMC.PK) announces that the United States Patent & Trademark office has granted a patent to the Company for its all inclusive urine point of collection drug test cup product lines, the Rapid TOX Cup II and the RDS® InCup. U.S. Patent Number 8,206,661 covers the Company’s all-inclusive cup product line and relates to an assay device for the testing of liquid samples for determining the presence of undesirable constituents, more particularly to a test device having a transparent container for retaining a liquid sample and test strips within the container for indicating visually the presence of particular drugs of abuse.

Back to news